Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -5.39x is 88% above its 4-year average of -44.80x, around the middle of its 4-year range (-132.64x–53.02x).
82.79% above its 12-month average of -31.33x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -5.88x.
INTEREST COVERAGE RATIO
-5.39x
INTEREST COVERAGE RATIO AVG TTM
-31.33x
INTEREST COVERAGE RATIO AVG 3Y
-46.22x
INTEREST COVERAGE RATIO AVG 5Y
-44.80x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+82.79%
CURRENT VS 3Y AVG
+88.34%
CURRENT VS 5Y AVG
+87.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-3.98x
median of 336 covered companies
CURRENT VS SECTOR MEDIAN
-35.60%
vs the sector median at left
Akanda Corp.
Market Cap
$61819.00
Interest Coverage Ratio
-5.39x
TTM Avg
-31.33x
3Y Avg
-46.22x
5Y Avg
-44.80x
Market Cap
$563178.00
Interest Coverage Ratio
-9.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$685948.00
Interest Coverage Ratio
-115.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$800351.00
Interest Coverage Ratio
-8287.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$872428.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$897948.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$901902.00
Interest Coverage Ratio
N/A
TTM Avg
354.05x
3Y Avg
372.60x
5Y Avg
299.52x
Market Cap
$1.01M
Interest Coverage Ratio
-2.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.08M
Interest Coverage Ratio
-290.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akanda Corp. (AKAN) | $61819.00 | -5.39x | -31.33x | -46.22x | -44.80x |
| HCW Biologics Inc. (HCWB)vs › | $563178.00 | -9.00x | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $685948.00 | -115.23x | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $800351.00 | -8287.21x | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $872428.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $897948.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | N/A | 354.05x | 372.60x | 299.52x |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -2.27x | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | -290.08x | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -7.46x | 10.39x | 21.90x | 21.90x |
Interest Coverage
-5.4x
Debt/Equity
N/A
Current Ratio
0.22
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -5.88x |
| 2025-12-31 | -4.11x |
| 2025-06-30 | -83.99x |
| 2024-12-31 | -106.34x |
| 2024-06-30 | -29.04x |
| 2023-12-31 | -67.80x |
| 2023-06-30 | -26.42x |
| 2022-12-31 | -132.64x |
| 2021-12-31 | 53.02x |
| 2020-12-31 | 1.01x |
| 2020-06-30 | -0.86x |
| 2019-12-31 | -1.83x |
| 2019-06-30 | -1.83x |
